ReviewCurrent microbiology2025
Harnessing Plant-Derived Terpenoids for Novel Approaches in Combating Bacterial and Parasite Infections in Veterinary and Agricultural Settings.
Review in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Unveiling Chemical Profile and Insecticidal Potential of Essential Oils from Leaves of SevenPlants (Basel, Switzerland) · 2026Article
- The antibacterial effect of Tanacetum argyrophyllum essential oil on kanamycin-resistant Escherichia coli by disruption of energy metabolism and proton fluxes.Scientific reports · 2026Article
- Phytohemical Profiling, Bioactivity and Toxicity Evaluation ofMolecules (Basel, Switzerland) · 2026Article
- Bacterial secondary metabolites as resistance-modifying adjuvants: microbial origins, molecular mechanisms, and translational relevance.Frontiers in microbiology · 2026Review
- Counteracting methicillin resistant Staphylococcus aureus through novel Citral-Azithromycin combination.Scientific reports · 2025Article
- Development of Bioactive Cotton, Wool, and Silk Fabrics Functionalized withPharmaceutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The rising resistance to conventional antimicrobial therapies in veterinary contexts poses a formidable challenge. While various innovative treatment strategies for pathogenic infections have emerged, their success still needs to be improved, warranting continued research. Recent investigations into natural products as potential sources for biologically active therapeutics have gained traction. Phytochemicals present a promising alternative in combating a spectrum of pathogens, including bacteria, fungi and parasites. One such class of phytochemicals with mounting potential is the structurally diverse terpenes. These chemicals contribute to plants' characteristic odour and medicinal effects and have been widely investigated in the scientific literature for their exceptional antibacterial activity. Their efficacy is demonstrated through diverse mechanisms, encompassing damage to bacterial membranes, suppression of virulence factors, and interference with enzymes, toxins, and biofilm formation. This review comprehensively examines terpenes' in vitro and in vivo activity and their derivatives against pathogens, elucidating their potential against antimicrobial resistance (AMR) and the underlying mechanisms specific to each terpene class. The findings underscore the burgeoning potential of terpene therapy as a viable alternative or supplementary approach to conventional antibiotics in addressing bacterial and parasitic infections in livestock and companion animals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.